Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-058822
Filing Date
2025-04-25
Accepted
2025-04-25 16:45:29
Documents
1
Period of Report
2025-04-25
Effectiveness Date
2025-04-25

Document Format Files

Seq Description Document Type Size
1 ARS 2024_10-k_ars.pdf ARS 6660311
  Complete submission text file 0000950170-25-058822.txt   9054138
Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40475 | Film No.: 25874870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)